Hospital
Grady Memorial Hospital Corporation
Grady Memorial Hospital Corporation was paid $1.69M by Medicaid between Jan 2018 and Sep 2024, across 91 billing codes. Its largest line is 99212, Office or other outpatient visit for the evaluation and management of an established patient, straightforward — 30% of everything it billed.
33Billing provider infoGRADY MEMORIAL HOSPITAL CORPORATION
ATLANTA, GA 30303
ATLANTA, GA 30303
33aNPI1992799050assigned 09/06/2005
33bProvider typeRehabilitation Hospital
28Total paid$1.69M
24GClaims54,302
24DCodes billed91
24AFirst – last monthJan 2018 – Sep 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MEYER, MARK controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,048 | $1.24M | |
| 2019 | 8,751 | $284K | |
| 2020 | 1,374 | $12K | |
| 2021 | 3,363 | $25K | |
| 2022 | 2,609 | $40K | |
| 2023 | 2,435 | $74K | |
| 2024incomplete | 722 | $18K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 30% | 5,261 | 4,582 | $506K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 2,351 | 1,899 | $240K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 10.0% | 1,138 | 857 | $168K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.9% | 1,243 | 975 | $150K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 5.3% | 1,161 | 882 | $89K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.4% | 557 | 508 | $57K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 3.2% | 537 | 459 | $53K |
| 76819 | Fetal biophysical profile; without non-stress testing | 3.0% | 602 | 236 | $51K |
| 80053 | Comprehensive metabolic panel | 2.6% | 6,085 | 4,321 | $44K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.7% | 82 | 75 | $29K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.6% | 715 | 641 | $27K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.4% | 979 | 745 | $23K |
79 more codes
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 1.0% | 298 | $17K |
| G0378 | Hospital observation service, per hour | <1% | 170 | $15K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 134 | $14K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 304 | $14K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,656 | $12K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 375 | $10K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 279 | $9K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 399 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 303 | $8K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 177 | $8K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 674 | $7K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 72 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 139 | $7K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,681 | $7K |
| 81025 | <1% | 1,472 | $6K | |
| 86850 | <1% | 570 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,609 | $6K |
| 76820 | <1% | 48 | $6K | |
| 86901 | <1% | 572 | $5K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 75 | $5K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,609 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 182 | $4K |
| 71045 | Radiologic examination, chest; single view | <1% | 58 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 976 | $4K |
| 87340 | <1% | 530 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 26 | $3K |
| 86787 | <1% | 207 | $3K | |
| 85027 | <1% | 1,069 | $3K | |
| 81001 | <1% | 2,820 | $3K | |
| 86762 | <1% | 229 | $3K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 955 | $3K |
| 80061 | Lipid panel | <1% | 433 | $3K |
| 83655 | <1% | 229 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 57 | $2K |
| 84702 | <1% | 442 | $2K | |
| 86592 | <1% | 923 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 356 | $2K |
| 86703 | <1% | 480 | $2K | |
| 84484 | <1% | 251 | $2K | |
| 80320 | <1% | 204 | $2K | |
| 76830 | Ultrasound, transvaginal | <1% | 15 | $2K |
| 86900 | <1% | 572 | $2K | |
| 83021 | <1% | 216 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 415 | $1K |
| 85018 | <1% | 615 | $1K | |
| 83690 | <1% | 253 | $975.44 | |
| 90715 | <1% | 246 | $967.84 | |
| 73560 | <1% | 28 | $965.68 | |
| 85610 | <1% | 404 | $831.00 | |
| 85730 | <1% | 171 | $758.15 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 239 | $758.13 |
| 72170 | <1% | 13 | $756.17 | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 14 | $709.20 |
| 81003 | <1% | 479 | $638.04 | |
| 82947 | <1% | 264 | $575.96 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 119 | $542.03 |
| 88142 | <1% | 368 | $468.67 | |
| 90656 | <1% | 187 | $244.52 | |
| 87186 | <1% | 54 | $241.81 | |
| 82950 | <1% | 298 | $214.08 | |
| 87077 | <1% | 56 | $193.29 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 107 | $153.98 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 87 | $122.52 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 100 | $120.50 |
| 86359 | <1% | 42 | $99.42 | |
| 87210 | <1% | 397 | $94.98 | |
| 84156 | <1% | 145 | $82.56 | |
| 90756 | <1% | 33 | $76.70 | |
| 82570 | <1% | 168 | $72.80 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 120 | $59.74 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 117 | $57.22 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 16 | $42.69 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 47 | $37.07 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 78 | $35.31 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 13 | $10.94 |
| 87536 | 0% | 14 | $0.00 | |
| 86803 | 0% | 13 | $0.00 | |
| 90686 | 0% | 13 | $0.00 | |
| 90670 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMEYER, MARK (CFO)
| Provider | Location | Paid |
|---|---|---|
| University of Texas Southwestern Medical Center at Dallas | Dallas, TX | $6.91M |
| Presbyterian Homes Hospice INC | Roseville, MN | $5.49M |
| University of Texas Southwestern Medical Center at Dallas | Plano, TX | $3.20M |
| University of Texas Southwestern Medical Center at Dallas | Dallas, TX | $2.08M |
| University of Texas Southwestern Medical Center at Dallas | El Paso, TX | $40K |
| PHS Maranatha INC. | Brooklyn Center, MN | $30K |
| University of Texas Southwestern Medical Center at Dallas | Dallas, TX | $30K |
| Grandview Christian Home | Cambridge, MN | $16K |
| University of Texas Southwestern Medical Center at Dallas | Fort Worth, TX | $10K |
| University of Texas Southwestern Medical Center at Dallas | Dallas, TX | $5K |
| University of Texas Southwestern Medical Center at Dallas | Dallas, TX | $2K |
| CG Care Center, LLC. | Cottage Grove, MN | $2K |
| Vssa Care Center LLC | Oak Park Heights, MN | $958.06 |
| Presbyterian Homes of Arden Hills INC | Arden Hills, MN | $0.00 |
| Bvm-Phs Senior Housing INC | Dubuque, IA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.